Cargando…

HIV-1 Tat-induced diarrhea is improved by the PPARalpha agonist, palmitoylethanolamide, by suppressing the activation of enteric glia

BACKGROUND: Diarrhea is a severe complication in HIV-1-infected patients with Trans-activator of transcription (HIV-1 Tat) protein being recognized as a major underlying cause. Beside its direct enterotoxic effects, Tat protein has been recently shown to affect enteric glial cell (EGC) activity. EGC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sarnelli, Giovanni, Seguella, Luisa, Pesce, Marcella, Lu, Jie, Gigli, Stefano, Bruzzese, Eugenia, Lattanzi, Roberta, D’Alessandro, Alessandra, Cuomo, Rosario, Steardo, Luca, Esposito, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5866515/ https://www.ncbi.nlm.nih.gov/pubmed/29573741 http://dx.doi.org/10.1186/s12974-018-1126-4

Ejemplares similares

HIV-1 Tat-induced diarrhea evokes an enteric glia-dependent neuroinflammatory response in the central nervous system
por: Esposito, Giuseppe, et al.
Publicado: (2017)

Rifaximin Improves Clostridium difficile Toxin A-Induced Toxicity in Caco-2 Cells by the PXR-Dependent TLR4/MyD88/NF-κB Pathway
por: Esposito, Giuseppe, et al.
Publicado: (2016)

Palmitoylethanolamide Modulates Inflammation-Associated Vascular Endothelial Growth Factor (VEGF) Signaling via the Akt/mTOR Pathway in a Selective Peroxisome Proliferator-Activated Receptor Alpha (PPAR-α)-Dependent Manner
por: Sarnelli, Giovanni, et al.
Publicado: (2016)

Oral Adelmidrol Administration Up-Regulates Palmitoylethanolamide Production in Mice Colon and Duodenum through a PPAR-γ Independent Action
por: Del Re, Alessandro, et al.
Publicado: (2022)

Leaky gut, dysbiosis, and enteric glia activation: the trilogy behind the intestinal origin of Parkinson’s disease
por: Seguella, Luisa, et al.
Publicado: (2019)

A Palmitoylethanolamide Producing Lactobacillus paracasei Improves Clostridium difficile Toxin A-Induced Colitis
por: Esposito, Giuseppe, et al.
Publicado: (2021)

Ultramicronized Palmitoylethanolamide Inhibits NLRP3 Inflammasome Expression and Pro-Inflammatory Response Activated by SARS-CoV-2 Spike Protein in Cultured Murine Alveolar Macrophages
por: Del Re, Alessandro, et al.
Publicado: (2021)

Impaired Duodenal Palmitoylethanolamide Release Underlies Acid-Induced Mast Cell Activation in Functional Dyspepsia
por: Sarnelli, Giovanni, et al.
Publicado: (2020)

Endocannabinoid‐related compounds in gastrointestinal diseases
por: Pesce, Marcella, et al.
Publicado: (2017)

Engineered Lactobacillus paracasei Producing Palmitoylethanolamide (PEA) Prevents Colitis in Mice
por: Esposito, Giuseppe, et al.
Publicado: (2021)

Autologous transplantation of intestine-isolated glia cells improves neuropathology and restores cognitive deficits in β amyloid-induced neurodegeneration
por: Esposito, Giuseppe, et al.
Publicado: (2016)

Can the enteric nervous system be an alternative entrance door in SARS-CoV2 neuroinvasion?
por: Esposito, Giuseppe, et al.
Publicado: (2020)

High-fat diet impairs duodenal barrier function and elicits glia-dependent changes along the gut-brain axis that are required for anxiogenic and depressive-like behaviors
por: Seguella, Luisa, et al.
Publicado: (2021)

Circuit-specific enteric glia regulate intestinal motor neurocircuits
por: Ahmadzai, Mohammad M., et al.
Publicado: (2021)

N-Palmitoyl-D-Glucosamine Inhibits TLR-4/NLRP3 and Improves DNBS-Induced Colon Inflammation through a PPAR-α-Dependent Mechanism
por: Palenca, Irene, et al.
Publicado: (2022)

The potential of cannabidiol in the COVID‐19 pandemic
por: Esposito, Giuseppe, et al.
Publicado: (2020)

Role of Enteric Glia as Bridging Element between Gut Inflammation and Visceral Pain Consolidation during Acute Colitis in Rats
por: Lucarini, Elena, et al.
Publicado: (2021)

Palmitoylethanolamide counteracts reactive astrogliosis induced by β-amyloid peptide
por: Scuderi, Caterina, et al.
Publicado: (2011)

PPARalpha-mediated effects of dietary lipids on intestinal barrier gene expression
por: de Vogel-van den Bosch, Heleen M, et al.
Publicado: (2008)

Palmitoylethanolamide and White Matter Lesions: Evidence for Therapeutic Implications
por: Valenza, Marta, et al.
Publicado: (2022)

S100B Protein Stimulates Proliferation and Angiogenic Mediators Release through RAGE/pAkt/mTOR Pathway in Human Colon Adenocarcinoma Caco-2 Cells
por: Seguella, Luisa, et al.
Publicado: (2019)

Metformin stimulates IGFBP-2 gene expression through PPARalpha in diabetic states
por: Kang, Hye Suk, et al.
Publicado: (2016)

The Bitter Taste Receptor Agonist Quinine Reduces Calorie Intake and Increases the Postprandial Release of Cholecystokinin in Healthy Subjects
por: Andreozzi, Paolo, et al.
Publicado: (2015)

Cannabidiol inhibits SARS‐Cov‐2 spike (S) protein‐induced cytotoxicity and inflammation through a PPARγ‐dependent TLR4/NLRP3/Caspase‐1 signaling suppression in Caco‐2 cell line
por: Corpetti, Chiara, et al.
Publicado: (2021)

Next-Generation Probiotics for Inflammatory Bowel Disease
por: Pesce, Marcella, et al.
Publicado: (2022)

Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α
por: Scuderi, Caterina, et al.
Publicado: (2012)

The antiprotozoal drug pentamidine ameliorates experimentally induced acute colitis in mice
por: Esposito, Giuseppe, et al.
Publicado: (2012)

S100B Inhibitor Pentamidine Attenuates Reactive Gliosis and Reduces Neuronal Loss in a Mouse Model of Alzheimer's Disease
por: Cirillo, Carla, et al.
Publicado: (2015)

Lipid-lowering fibrates extend C. elegans lifespan in a NHR-49/PPARalpha-dependent manner
por: Brandstädt, Sven, et al.
Publicado: (2013)

Identification of Binding Regions of Bilirubin in the Ligand-Binding Pocket of the Peroxisome Proliferator-Activated Receptor-A (PPARalpha)
por: Gordon, Darren M., et al.
Publicado: (2021)

Palmitoylethanolamide controls reactive gliosis and exerts neuroprotective functions in a rat model of Alzheimer's disease
por: Scuderi, C, et al.
Publicado: (2014)

The role of enteric glia in intestinal immunity
por: Progatzky, Fränze, et al.
Publicado: (2022)

Nutraceuticals and Diet Supplements in Crohn’s Disease: A General Overview of the Most Promising Approaches in the Clinic
por: De Conno, Barbara, et al.
Publicado: (2022)

Sleeve Gastrectomy-Induced Body Mass Index Reduction Increases the Intensity of Taste Perception’s and Reduces Bitter-Induced Pleasantness in Severe Obesity
por: Rurgo, Sara, et al.
Publicado: (2022)

Palmitoylethanolamide Dampens Reactive Astrogliosis and Improves Neuronal Trophic Support in a Triple Transgenic Model of Alzheimer's Disease: In Vitro and In Vivo Evidence
por: Bronzuoli, Maria Rosanna, et al.
Publicado: (2018)

Development, Diversity, and Neurogenic Capacity of Enteric Glia
por: Boesmans, Werend, et al.
Publicado: (2022)

Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain
por: Impellizzeri, Daniela, et al.
Publicado: (2014)

Vitamin A Ameliorated Irinotecan-Induced Diarrhea in a Piglet Model Involving Enteric Glia Modulation and Immune Cells Infiltration
por: Li, Meng, et al.
Publicado: (2022)

Looking for a Treatment for the Early Stage of Alzheimer’s Disease: Preclinical Evidence with Co-Ultramicronized Palmitoylethanolamide and Luteolin
por: Facchinetti, Roberta, et al.
Publicado: (2020)

Erratum to: Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain
por: Impellizzeri, Daniela, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_iudn5t678vqaoml6setpbmssov